Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
IPO Year:
Exchange: NYSE
Website: chemed.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 9/2/2025 | $550.00 | Hold → Buy | Jefferies |
| 7/25/2025 | $500.00 | Hold | Jefferies |
| 3/4/2022 | $609.00 → $579.00 | Outperform | RBC Capital |
| 7/29/2021 | $604.00 → $609.00 | Outperform | RBC Capital |
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - CHEMED CORP (0000019584) (Issuer)
4 - CHEMED CORP (0000019584) (Issuer)
Fastest customizable press release news feed in the world
CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET). The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the
Stacy Noland reveals how VITAS brought comfort and dignity during her mother's final days. MIRAMAR, Fla., Nov. 25, 2025 /PRNewswire/ -- A new video released by VITAS Healthcare during National Care at Home Month spotlights the hospice story of Stacy Noland and her mother, Sonia Lindo, whose final chapter was marked by compassion and dignity. The expert end-of-life care they received allowed Noland to focus on what mattered most: being a daughter. Lindo, a Jamaican-born cardiac nurse of 30 years saved countless lives before facing her own terminal diagnosis. "When my mother got sick, it stunned me," Noland said. "She was strong, healthy and dedicated to her patie
CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This represents the 218th consecutive quarterly dividend paid by Chemed in its 54 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hos
CINCINNATI, Ohio, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the UBS 2025 Global Healthcare Conference on Tuesday, November 11, 2025, at approximately 2:00 p.m. (ET) at the PGA National Resort in Palm Beach Gardens, Florida. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) ope
CINCINNATI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2025, versus the comparable prior-year period. Results for Quarter Ended September 30, 2025 Consolidated operating results: Revenue increased 3.1% to $624.9 millionGAAP Diluted Earnings-per-Share (EPS) of $4.46, a decrease of 10.8%Adjusted Diluted EPS of $5.27, a decrease of 6.6% VITAS segment operating results: Net Pati
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2025, on Tuesday, October 28, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, October 29, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/9m3ch5my. Participants may also register via teleconference a
MIRAMAR, Fla., Sept. 25, 2025 /PRNewswire/ -- VITAS Healthcare, the nation's leading provider of end-of-life care, has been named a 2025 Top Workplace in Healthcare by Top Workplaces USA, a national program that honors organizations based solely on employee feedback. VITAS is one of only 57 healthcare organizations nationwide with more than 1,000 employees to receive this distinction. The award reflects VITAS' ongoing commitment to fostering a purpose-driven culture that supports its employees and enhances the quality of hospice and palliative care delivered to patients and families. "This honor belongs to our employees," said Ava Padmore-Lewis, senior vice pres
Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Jefferies 2025 Healthcare Services Conference on Tuesday, September 30, 2025, at approximately 1:50 p.m. (CT) at the 1 Hotel in Nashville. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. V
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on August 29, 2025, to shareholders of record as of August 11, 2025. This is a 10-cent, or 20.0%, increase over the 50-cent dividend paid in June 2025. The previous increase was in August 2024, when the Board raised the quar
MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation's leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE:CHE), today announced that Nicholas M. Westfall will step down as chairman and chief executive officer to pursue other personal and professional opportunities. Joel L. Wherley, president and chief operating officer, was appointed by the Board to succeed Westfall as chief executive officer of VITAS Healthcare. A Media Snippet accompanying this announcement is available by clicking on this link. Westfall has served as CEO since 2016, leading VITAS through a period of meaningful growth, operational transform
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Jefferies upgraded Chemed from Hold to Buy and set a new price target of $550.00
Jefferies initiated coverage of Chemed with a rating of Hold and set a new price target of $500.00
RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $579.00 from $609.00 previously
RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $609.00 from $604.00 previously
Oppenheimer reiterated coverage of Chemed with a rating of Outperform and set a new price target of $580.00 from $600.00 previously
Oppenheimer reiterated coverage of Chemed with a rating of Outperform and set a new price target of $580.00 from $600.00 previously
10-Q - CHEMED CORP (0000019584) (Filer)
8-K - CHEMED CORP (0000019584) (Filer)
10-Q - CHEMED CORP (0000019584) (Filer)
8-K - CHEMED CORP (0000019584) (Filer)
8-K - CHEMED CORP (0000019584) (Filer)
11-K - CHEMED CORP (0000019584) (Filer)
S-8 POS - CHEMED CORP (0000019584) (Filer)
8-K - CHEMED CORP (0000019584) (Filer)
S-8 - CHEMED CORP (0000019584) (Filer)
10-Q - CHEMED CORP (0000019584) (Filer)
Live Leadership Updates
MIRAMAR, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- VITAS Healthcare, one of the nation's leading providers of hospice and palliative care, and a subsidiary of Chemed Corporation (NYSE:CHE), today announced that Nicholas M. Westfall will step down as chairman and chief executive officer to pursue other personal and professional opportunities. Joel L. Wherley, president and chief operating officer, was appointed by the Board to succeed Westfall as chief executive officer of VITAS Healthcare. A Media Snippet accompanying this announcement is available by clicking on this link. Westfall has served as CEO since 2016, leading VITAS through a period of meaningful growth, operational transform
VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra
Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t
Chemed Corporation (NYSE:CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Williams has announced that he will retire as Chemed's Chief Financial Officer as of December 31, 2023, but Mr. Williams will continue to work with Chemed for the transition period and beyond in providing his guidance and the benefit of his expertise to the executive team and the Board of Directors. Throughout his career, David helped lead Chemed and its subsidiaries through unprecedented economic growth. "It has been a privilege to work with David as an integral part of our management team for these last three decades," said Chemed Chief Executive Officer, Kevin
This live feed shows all institutional transactions in real time.
SC 13G/A - CHEMED CORP (0000019584) (Subject)
SC 13G/A - CHEMED CORP (0000019584) (Subject)
SC 13G/A - CHEMED CORP (0000019584) (Subject)
SC 13G/A - CHEMED CORP (0000019584) (Subject)
Live finance-specific insights
CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This represents the 218th consecutive quarterly dividend paid by Chemed in its 54 years as a public company. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of end-of-life hos
CINCINNATI, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest provider of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2025, versus the comparable prior-year period. Results for Quarter Ended September 30, 2025 Consolidated operating results: Revenue increased 3.1% to $624.9 millionGAAP Diluted Earnings-per-Share (EPS) of $4.46, a decrease of 10.8%Adjusted Diluted EPS of $5.27, a decrease of 6.6% VITAS segment operating results: Net Pati
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the third quarter ended September 30, 2025, on Tuesday, October 28, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Wednesday, October 29, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/9m3ch5my. Participants may also register via teleconference a
Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These shares repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility. The Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on August 29, 2025, to shareholders of record as of August 11, 2025. This is a 10-cent, or 20.0%, increase over the 50-cent dividend paid in June 2025. The previous increase was in August 2024, when the Board raised the quar
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its second quarter ended June 30, 2025, versus the comparable prior-year period. Results for Quarter Ended June 30, 2025 Consolidated operating results: Revenue increased 3.8% to $618.8 million GAAP Diluted Earnings-per-Share (EPS) of $3.57, a decrease of 23.2% Adjusted Diluted EPS of $4.27, a decrease of 21.9% VITAS segment operating results: Net Patient Revenue of $396.2 milli
Provides Current Update to 2025 Earnings Performance Related Conference Call to Be Held On July 30, 2025 Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the second quarter ended June 30, 2025, on Tuesday, July 29, 2025, following the close of trading on the New York Stock Exchange. Chemed also announced developments related to second quarter earnings and full year 2025 guidance. In prior public statements, management discussed the possibility that the VITAS subsidiary could have an aggregate Medicare Cap billing limitation (Medicare Cap) related to its Florida consolidated program, excluding Tallahassee. However, as of the most recent quarter
Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 50 cents per share on the Company's capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed's
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2025, versus the comparable prior-year period. Results for Quarter Ended March 31, 2025 Consolidated operating results: Revenue increased 9.8% to $646.9 million GAAP Diluted Earnings-per-Share (EPS) of $4.86, an increase of 14.6% Adjusted Diluted EPS of $5.63, an increase of 8.3% VITAS segment operating results: Net Patient Revenue of $407.4 million, an in
Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 24, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/ey8mpmti. Participants may also register via teleconference at: https:/
Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2024, versus the comparable prior-year period. Changes to Non-GAAP Metrics Chemed uses certain non-GAAP metrics such as EBITDA, adjusted EBITDA, adjusted net income and adjusted diluted earnings per share, to provide additional context and perspective to reported operational results. Chemed's previously reported non-GAAP metrics during the four sequential qu